No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients after Three Years of Darunavir/Ritonavir with and without Nucleoside Analogues in the MONET Trial

• Ajantha Solomon,

  Affiliation Department of Infectious Diseases, Monash University and Alfred Health, Centre for Biomedical Research, Burnet Institute, Melbourne, Australia

  ⨯
• Surekha Tennakoon,

  Affiliation Department of Infectious Diseases, Monash University and Alfred Health, Centre for Biomedical Research, Burnet Institute, Melbourne, Australia

  ⨯
• Edwin Leeansyah,

  Affiliation Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden

  ⨯
• Jose Arribas,

  Affiliation Hospital la Paz, IdiPAZ, Madrid, Spain

  ⨯
• Andrew Hill,

  Affiliation Janssen, High Wycombe, United Kingdom

  ⨯
• Yvon Van Delft,

  Affiliation Janssen, Tilburg, Netherlands

  ⨯
• Christiane Moecklinghoff,

  Affiliation Janssen, Neuss, Germany

  ⨯
• Sharon R. Lewin

  * E-mail: lewins@unimelb.edu.au

  Affiliation Department of Infectious Diseases, Monash University and Alfred Health, Centre for Biomedical Research, Burnet Institute, Melbourne, Australia

  ⨯